Stocks · News reference
Nuwellis Expanding Capabilities Of Aquadex SmartFlow System Into Broader Extracorporeal Therapy Platform
Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced strategic development initiatives to expand the capabilities of its
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Nuwellis shares are trading higher after the company announced continued commercial momentum for its Aquadex SmartFlow system, with 31 consoles sold year-to-date in 2026.
Nuwellis Says 31 Aquadex SmartFlow Consoles Sold Year-To-Date In 2026, Exceeding Full-Year Totals In Seven Of Past 10 Years; Reiterates 26% U.S. Revenue Growth In First Half
Nuwellis Says Financial Efficiency Strategy Drove Q2 2026 Gross Margin To 76% From 56%; Says It Had About $8.8M In Cash As Of August 31, With Runway Into Q3 2027